Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Xerostomia 1Stomatitis 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Xylitol × Clear all
NCT04608773 2024-02-01

Blinded Dry Mouth Spray Crossover Study

University of Pittsburgh

Phase NA Completed
129 enrolled 12 charts
Head & Neck

Head and Neck Neoplasms, Xerostomia

NCT01898091 2017-03-06

OM

Medical University of South Carolina

Phase 2 Completed
50 enrolled 9 charts
Other

Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡